45 related articles for article (PubMed ID: 9023642)
1. Fluconazole versus mould-active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost-effectiveness analysis.
Wang Y; Xing Y; Chen L; Meng T; Li Y; Xie J; Chen L; Dong Y; Dong W
Int J Hematol; 2018 Feb; 107(2):235-243. PubMed ID: 29027638
[TBL] [Abstract][Full Text] [Related]
2. Invasive Candidiasis due to Candida Norvegensis in a Liver Transplant Patient: Case Report and Literature Review.
Musso M; Giannella M; Antonini M; Bordi E; Ettorre GM; Tessitore L; Mariano A; Capone A
Infect Dis Rep; 2014 May; 6(2):5374. PubMed ID: 25002960
[TBL] [Abstract][Full Text] [Related]
3. Itraconazole associated quadriparesis and edema: a case report.
Karadi RL; Gow D; Kellett M; Denning DW; O'Driscoll RB
J Med Case Rep; 2011 Apr; 5():140. PubMed ID: 21477327
[TBL] [Abstract][Full Text] [Related]
4. Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.
Cornely OA; Böhme A; Buchheidt D; Einsele H; Heinz WJ; Karthaus M; Krause SW; Krüger W; Maschmeyer G; Penack O; Ritter J; Ruhnke M; Sandherr M; Sieniawski M; Vehreschild JJ; Wolf HH; Ullmann AJ
Haematologica; 2009 Jan; 94(1):113-22. PubMed ID: 19066334
[TBL] [Abstract][Full Text] [Related]
5. Itraconazole antagonizes store-operated influx of calcium into chemoattractant-activated human neutrophils.
Steel HC; Anderson R
Clin Exp Immunol; 2004 May; 136(2):255-61. PubMed ID: 15086388
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Transplantation: Pre-transplant Infectious Diseases Evaluation and Post-transplant Prophylaxis.
Keay S
Curr Infect Dis Rep; 2002 Aug; 4(4):285-292. PubMed ID: 12126604
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with itraconazole in systemic fungal infections.
Boogaerts M; Maertens J
Drugs; 2001; 61 Suppl 1():39-47. PubMed ID: 11219549
[TBL] [Abstract][Full Text] [Related]
8. Experimental model of progressive disseminated trichosporonosis in mice with latent trichosporonemia.
Yamagata E; Kamberi P; Yamakami Y; Hashimoto A; Nasu M
J Clin Microbiol; 2000 Sep; 38(9):3260-6. PubMed ID: 10970368
[TBL] [Abstract][Full Text] [Related]
9. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
Kibbler CC
Mycoses; 1999; 42 Suppl 2():121-4. PubMed ID: 10865918
[TBL] [Abstract][Full Text] [Related]
10. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
Glasmacher A; Prentice AG
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
[TBL] [Abstract][Full Text] [Related]
11. Itraconazole for prophylaxis of systemic mycoses in neutropenic patients with haematological malignancies.
Böhme A; Just-Nübling G; Bergmann L; Shah PM; Stille W; Hoelzer D
J Antimicrob Chemother; 1996 Dec; 38(6):953-61. PubMed ID: 9023642
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group.
Morgenstern GR; Prentice AG; Prentice HG; Ropner JE; Schey SA; Warnock DW
Br J Haematol; 1999 Jun; 105(4):901-11. PubMed ID: 10554799
[TBL] [Abstract][Full Text] [Related]
13. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
Harousseau JL; Dekker AW; Stamatoullas-Bastard A; Fassas A; Linkesch W; Gouveia J; De Bock R; Rovira M; Seifert WF; Joosen H; Peeters M; De Beule K
Antimicrob Agents Chemother; 2000 Jul; 44(7):1887-93. PubMed ID: 10858349
[TBL] [Abstract][Full Text] [Related]
14. The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea.
Kim JS; Cheong JW; Kim YK; Park J; Mun YC; Kang HJ; Yi HG; Lee JH; Kim YS; Ryoo HM; Kim SH; Kim HY; Kim JY; Lee DG; Kim HG; Kim H; Joo YD; Min YH
Ann Hematol; 2014 Jan; 93(1):33-42. PubMed ID: 23807252
[TBL] [Abstract][Full Text] [Related]
15. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
